Alessa Therapeutics

San Francisco, United States

Alessa Therapeutics develops localized treatments for solid organ disease.

$15.0M raised

Dec 2024

Seed

Biotechnology Health Care Therapeutics

Top Investors

Mission BioCapitalJohnson & Johnson

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Alessa Therapeutics

How much funding has Alessa Therapeutics raised?

Alessa Therapeutics has raised $15.0M in total funding. The most recent round was Seed. The last funding was announced in December 2024.

Who are Alessa Therapeutics's investors?

Alessa Therapeutics's investors include Mission BioCapital, Johnson & Johnson.

Where is Alessa Therapeutics headquartered?

Alessa Therapeutics is headquartered in San Francisco, United States.

What does Alessa Therapeutics do?

Alessa Therapeutics develops localized treatments for solid organ disease.

What stage is Alessa Therapeutics at?

Alessa Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 12, 2024.

MLA

"Alessa Therapeutics — Funding & Investors." VCBacked, December 12, 2024, https://www.vcbacked.co/company/alessa-therapeutics. Accessed June 17, 2026.

APA

VCBacked. (2024). Alessa Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/alessa-therapeutics

Wikipedia (cite web)

{{cite web |title=Alessa Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/alessa-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 12, 2024.